Sydney (16 April 2020)
Valuation Research Group (VRG), a leading global provider of independent valuation, advisory and value-related services is pleased to announce that our Australia-based member firm, Leadenhall, has just released a new article, “Impact of COVID-19 on Impairment Analysis.”
Drastic changes in operating conditions and financial markets this year pose significant challenges for all of us involved in financial reporting and forecasting. For any company that has made an acquisition in the last few years, impairment analysis will require deeper consideration and will likely receive greater scrutiny from auditors and ASIC than in prior years.
Impact of COVID-19 on Impairment Analysis
Connect now to let us know how we can solve your valuation challenges.